Rohto Pharmaceutical Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Revenue	333,800	308,625	270,840	238,664	199,646	181,287	Upgrade
Revenue Growth (YoY)	18.35%	13.95%	13.48%	19.54%	10.13%	-3.74%	Upgrade
Cost of Revenue	146,186	133,686	113,554	101,243	83,157	74,560	Upgrade
Gross Profit	187,614	174,939	157,286	137,421	116,489	106,727	Upgrade
Selling, General & Admin	126,670	115,521	101,377	89,859	76,435	73,933	Upgrade
Research & Development	14,912	14,912	13,390	11,065	8,740	7,903	Upgrade
Amortization of Goodwill & Intangibles	1,523	1,523	436	383	457	372	Upgrade
Operating Expenses	147,583	136,474	117,119	103,883	88,297	84,860	Upgrade
Operating Income	40,031	38,465	40,167	33,538	28,192	21,867	Upgrade
Interest Expense	-1,423	-949	-196	-247	-248	-145	Upgrade
Interest & Investment Income	5,520	1,922	2,009	2,285	751	1,532	Upgrade
Earnings From Equity Investments	242	166	-289	56	143	396	Upgrade
Currency Exchange Gain (Loss)	1,376	516	447	-	-	-	Upgrade
Other Non Operating Income (Expenses)	703	311	294	-64	245	260	Upgrade
EBT Excluding Unusual Items	46,449	40,431	42,432	35,568	29,083	23,910	Upgrade
Gain (Loss) on Sale of Investments	831	1,896	-798	-160	-368	787	Upgrade
Asset Writedown	-159	-175	-348	-1,338	-892	-1,691	Upgrade
Other Unusual Items	179	179	230	219	129	-	Upgrade
Pretax Income	47,300	42,331	41,516	34,289	27,952	23,006	Upgrade
Income Tax Expense	11,387	11,379	10,123	7,860	6,803	6,236	Upgrade
Earnings From Continuing Operations	35,913	30,952	31,393	26,429	21,149	16,770	Upgrade
Minority Interest in Earnings	-176	54	-457	-52	-131	-27	Upgrade
Net Income	35,737	31,006	30,936	26,377	21,018	16,743	Upgrade
Net Income to Common	35,737	31,006	30,936	26,377	21,018	16,743	Upgrade
Net Income Growth	31.08%	0.23%	17.28%	25.50%	25.53%	8.65%	Upgrade
Shares Outstanding (Basic)	227	228	228	228	228	228	Upgrade
Shares Outstanding (Diluted)	230	229	229	229	229	229	Upgrade
Shares Change (YoY)	0.59%	0.04%	-	-0.00%	-	0.01%	Upgrade
EPS (Basic)	157.63	136.11	135.60	115.62	92.13	73.39	Upgrade
EPS (Diluted)	155.27	135.44	135.21	115.29	91.86	73.18	Upgrade
EPS Growth	30.32%	0.17%	17.28%	25.50%	25.53%	8.65%	Upgrade
Free Cash Flow	31,697	27,837	26,266	22,451	16,983	11,287	Upgrade
Free Cash Flow Per Share	137.73	121.61	114.80	98.13	74.23	49.33	Upgrade
Dividend Per Share	20.000	36.000	27.000	22.000	18.000	14.000	Upgrade
Dividend Growth	-35.48%	33.33%	22.73%	22.22%	28.57%	7.69%	Upgrade
Gross Margin	56.21%	56.68%	58.07%	57.58%	58.35%	58.87%	Upgrade
Operating Margin	11.99%	12.46%	14.83%	14.05%	14.12%	12.06%	Upgrade
Profit Margin	10.71%	10.05%	11.42%	11.05%	10.53%	9.24%	Upgrade
Free Cash Flow Margin	9.50%	9.02%	9.70%	9.41%	8.51%	6.23%	Upgrade
EBITDA	56,806	51,608	48,854	41,339	35,865	28,615	Upgrade
EBITDA Margin	17.02%	16.72%	18.04%	17.32%	17.96%	15.78%	Upgrade
D&A For EBITDA	16,775	13,143	8,687	7,801	7,673	6,748	Upgrade
EBIT	40,031	38,465	40,167	33,538	28,192	21,867	Upgrade
EBIT Margin	11.99%	12.46%	14.83%	14.05%	14.12%	12.06%	Upgrade
Effective Tax Rate	24.07%	26.88%	24.38%	22.92%	24.34%	27.11%	Upgrade
Advertising Expenses	-	57,506	54,219	46,467	38,114	40,525	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.